CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 78.1% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
20.13
2.85%
Market Trading Hours* (UTC) Opens on Tuesday at 14:30

Mon - Fri: 14:30 - 21:00

  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
  • Ownership
Trading сonditions
Spread 0.12
Long position overnight fee

Long position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.026179 %
Charges from full value of position ($-4.97)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.026179%
Short position overnight fee

Short position overnight fee


Margin. Your investment $1,000.00
Overnight fee 0.003957 %
Charges from full value of position ($0.75)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.003957%
Overnight fee time 22:00 (UTC)
Min traded quantity 1
Currency USD
Margin 5%
Stock exchange United States of America
Commission on trade 0%

*Information provided by Capital.com

Chemours Co ESG Risk Ratings

High Medium Low Negligible

‘C’ score indicates satisfactory relative ESG performance and moderate degree of transparency in reporting material ESG data publicly.

More ESG coverage

Key Stats
Prev. Close* 20.72
Open* 20.97
1-Year Change* -42.94%
Day's Range* 19.99 - 20.97
52 wk Range 22.88-39.05
Average Volume (10 days) 977.39K
Average Volume (3 months) 25.04M
Market Cap 4.36B
P/E Ratio -100.00K
Shares Outstanding 148.44M
Revenue 6.00B
EPS -2.08
Dividend (Yield %) 3.40716
Beta 2.08
Next Earnings Date Feb 14, 2024

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Mar 4, 2024 20.13 -0.34 -1.66% 20.47 21.05 19.89
Mar 1, 2024 20.72 1.22 6.26% 19.50 21.03 19.50
Feb 29, 2024 19.59 1.11 6.01% 18.48 20.48 15.05
Feb 28, 2024 28.65 0.38 1.34% 28.27 28.89 28.26
Feb 27, 2024 28.87 0.03 0.10% 28.84 29.35 28.72
Feb 26, 2024 28.80 -0.26 -0.89% 29.06 29.50 28.71
Feb 23, 2024 29.35 0.13 0.44% 29.22 29.73 28.99
Feb 22, 2024 29.64 0.70 2.42% 28.94 29.77 28.91
Feb 21, 2024 28.96 0.82 2.91% 28.14 28.97 28.14
Feb 20, 2024 28.27 0.82 2.99% 27.45 28.52 27.27
Feb 16, 2024 27.95 0.59 2.16% 27.36 28.71 27.36
Feb 15, 2024 27.75 0.90 3.35% 26.85 28.05 26.85
Feb 14, 2024 26.58 -1.60 -5.68% 28.18 28.30 26.44
Feb 13, 2024 30.43 0.64 2.15% 29.79 30.59 29.79
Feb 12, 2024 31.11 1.27 4.26% 29.84 31.69 29.84
Feb 9, 2024 30.03 0.33 1.11% 29.70 30.15 29.33
Feb 8, 2024 29.84 0.04 0.13% 29.80 30.03 29.44
Feb 7, 2024 29.85 -0.09 -0.30% 29.94 30.15 29.05
Feb 6, 2024 29.97 0.52 1.77% 29.45 30.77 29.45
Feb 5, 2024 29.73 -0.22 -0.73% 29.95 30.10 29.36

Chemours Events

Time (UTC) Country Event
Tuesday, March 5, 2024

Time (UTC)

21:00

Country

US

Event

Q4 2023 Chemours Co Earnings Release
Q4 2023 Chemours Co Earnings Release

Forecast

-

Previous

-
Thursday, April 25, 2024

Time (UTC)

10:59

Country

US

Event

Q1 2024 Chemours Co Earnings Release
Q1 2024 Chemours Co Earnings Release

Forecast

-

Previous

-

Time (UTC)

14:00

Country

US

Event

Chemours Co Annual Shareholders Meeting
Chemours Co Annual Shareholders Meeting

Forecast

-

Previous

-
View all events
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total revenue 6794 6345 4969 5526 6638
Revenue 6794 6345 4969 5526 6638
Cost of Revenue, Total 5178 4964 3902 4463 4667
Gross Profit 1616 1381 1067 1063 1971
Total Operating Expense 6015 5690 4624 5178 5493
Selling/General/Admin. Expenses, Total 710 592 527 548 594
Research & Development 118 107 93 80 82
Unusual Expense (Income) 9 27 102 87 150
Operating Income 779 655 345 348 1145
Interest Income (Expense), Net Non-Operating -123 -139 -213 -181 -151
Gain (Loss) on Sale of Assets 21 115 8 10 45
Other, Net 64 45 39 -301 116
Net Income Before Taxes 741 676 179 -124 1155
Net Income After Taxes 578 608 219 -52 986
Minority Interest 0 0 -1
Net Income Before Extra. Items 578 608 219 -52 985
Total Extraordinary Items 0 10
Net Income 578 608 219 -52 995
Income Available to Common Excl. Extra. Items 578 608 219 -52 985
Income Available to Common Incl. Extra. Items 578 608 219 -52 995
Diluted Net Income 578 608 219 -52 995
Diluted Weighted Average Shares 158.303 168.698 166.347 164.817 182.572
Diluted EPS Excluding Extraordinary Items 3.65123 3.60406 1.31653 -0.3155 5.39513
Dividends per Share - Common Stock Primary Issue 1 1 1 1 0.84
Diluted Normalized EPS 4.71062 4.49442 1.88312 0.69016 5.97494
Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022
Total revenue 1487 1643 1536 1338 1777
Revenue 1487 1643 1536 1338 1777
Cost of Revenue, Total 1206 1233 1168 1136 1345
Gross Profit 281 410 368 202 432
Total Operating Expense 1524 2039 1334 1347 1509
Selling/General/Admin. Expenses, Total 165 779 124 175 140
Research & Development 28 28 26 30 32
Unusual Expense (Income) 125 -1 16 6 -8
Operating Income -37 -396 202 -9 268
Interest Income (Expense), Net Non-Operating -42 -40 -37 -55 -12
Other, Net 102 3 8 1 43
Net Income Before Taxes 23 -433 173 -69 299
Net Income After Taxes 20 -376 145 -97 240
Net Income Before Extra. Items 20 -376 145 -97 240
Net Income 20 -376 145 -97 240
Income Available to Common Excl. Extra. Items 20 -376 145 -97 240
Income Available to Common Incl. Extra. Items 20 -376 145 -97 240
Diluted Net Income 20 -376 145 -97 240
Diluted Weighted Average Shares 150.186 149.096 151.179 149.988 157.85
Diluted EPS Excluding Extraordinary Items 0.13317 -2.52187 0.95913 -0.64672 1.52043
Dividends per Share - Common Stock Primary Issue 0.25 0.25 0.25 0.25 0.25
Diluted Normalized EPS 0.93218 0.20289 0.97576 1.11275 1.54077
Gain (Loss) on Sale of Assets 0 0 -6 0
Minority Interest 0 0
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total Current Assets 3214 3345 2633 2777 3293
Cash and Short Term Investments 1102 1451 1105 943 1201
Cash & Equivalents 1102 1451 1105 943 1201
Total Receivables, Net 626 720 511 672 857
Accounts Receivable - Trade, Net 509 644 449 600 786
Total Inventory 1404 1099 939 1079 1147
Prepaid Expenses 82 75 78 81 84
Other Current Assets, Total 2 4
Total Assets 7640 7550 7082 7258 7362
Property/Plant/Equipment, Total - Net 3411 3381 3710 3853 3291
Property/Plant/Equipment, Total - Gross 9627 9459 9818 9707 8992
Accumulated Depreciation, Total -6216 -6078 -6108 -5854 -5701
Goodwill, Net 102 102 153 153 153
Intangibles, Net 13 6 14 21 28
Long Term Investments 175 169 167 162 160
Note Receivable - Long Term
Other Long Term Assets, Total 725 547 405 292 437
Total Current Liabilities 1891 1858 1442 1541 1709
Accounts Payable 1228 1141 820 901 1111
Accrued Expenses 328 384 308 236 300
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 25 25 21 134 13
Other Current Liabilities, Total 310 308 293 270 285
Total Liabilities 6533 6469 6269 6569 6348
Total Long Term Debt 3590 3724 4005 4026 3959
Long Term Debt 3541 3664 3938 3972 3959
Deferred Income Tax 61 49 36 118 217
Minority Interest 0 1 2 6 6
Other Liabilities, Total 991 837 784 878 457
Total Equity 1107 1081 813 689 1014
Common Stock 2 2 2 2 2
Additional Paid-In Capital 1016 944 890 859 860
Retained Earnings (Accumulated Deficit) 2170 1746 1303 1249 1466
Other Equity, Total -343 -364 -310 -349 -564
Total Liabilities & Shareholders’ Equity 7640 7550 7082 7258 7362
Total Common Shares Outstanding 148.504 161.047 164.921 163.574 170.78
Treasury Stock - Common -1738 -1247 -1072 -1072 -750
Capital Lease Obligations 49 60 67 54
Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022
Total Current Assets 3683 3374 3202 3214 3543
Cash and Short Term Investments 852 738 816 1102 1167
Cash & Equivalents 852 738 816 1102 1167
Total Receivables, Net 846 890 837 626 980
Accounts Receivable - Trade, Net 753 782 722 509 844
Total Inventory 1314 1446 1486 1404 1321
Prepaid Expenses 76 64 63 82 75
Total Assets 7948 7660 7624 7640 7745
Property/Plant/Equipment, Total - Net 3377 3434 3418 3411 3303
Property/Plant/Equipment, Total - Gross 9501 9792 9737 9627 9418
Accumulated Depreciation, Total -6124 -6358 -6319 -6216 -6115
Goodwill, Net 102 102 102 102 102
Intangibles, Net 5 8 10 13 15
Long Term Investments 192 189 185 175 186
Other Long Term Assets, Total 589 553 707 725 596
Total Current Liabilities 2195 2190 1745 1891 1951
Accounts Payable 878 979 1142 1228 1270
Accrued Expenses 941 872 275 328 327
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 23 25 25 25 24
Other Current Liabilities, Total 353 314 303 310 330
Total Liabilities 7193 6852 6397 6533 6461
Total Long Term Debt 3944 3604 3599 3590 3510
Long Term Debt 3944 3604 3599 3590 3510
Deferred Income Tax 54 58 60 61 53
Minority Interest 2 2 1 0 1
Other Liabilities, Total 998 998 992 991 946
Total Equity 755 808 1227 1107 1284
Common Stock 2 2 2 2 2
Additional Paid-In Capital 1030 1014 1004 1016 1015
Retained Earnings (Accumulated Deficit) 1845 1864 2278 2170 2304
Treasury Stock - Common -1807 -1790 -1751 -1738 -1604
Other Equity, Total -315 -282 -306 -343 -433
Total Liabilities & Shareholders’ Equity 7948 7660 7624 7640 7745
Total Common Shares Outstanding 148.364 148.23 149.108 148.504 153.079
Other Current Assets, Total 595 236
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Net income/Starting Line 578 608 219 -52 996
Cash From Operating Activities 754 820 807 650 1140
Cash From Operating Activities 291 317 320 311 284
Deferred Taxes 20 -77 -120 -165 23
Non-Cash Items -31 -55 32 418 43
Cash Taxes Paid 131 149 78 85 75
Cash Interest Paid 164 180 208 204 206
Changes in Working Capital -104 27 356 138 -206
Cash From Investing Activities -284 220 -234 -483 -487
Capital Expenditures -307 -277 -267 -481 -498
Other Investing Cash Flow Items, Total 23 497 33 -2 11
Cash From Financing Activities -685 -560 -449 -419 -993
Financing Cash Flow Items -8 -32 -26 -30 -29
Total Cash Dividends Paid -154 -164 -164 -164 -148
Issuance (Retirement) of Stock, Net -444 -150 16 -313 -628
Issuance (Retirement) of Debt, Net -79 -214 -275 88 -188
Foreign Exchange Effects -32 -34 38 -6 -15
Net Change in Cash -247 446 162 -258 -355
Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
Net income/Starting Line 145 578 675 434 234
Cash From Operating Activities -119 754 594 293 2
Cash From Operating Activities 79 291 217 146 74
Deferred Taxes 1 20 6 -9 19
Non-Cash Items 1 -31 -61 -35 12
Changes in Working Capital -345 -104 -243 -243 -337
Cash From Investing Activities -97 -284 -219 -145 -110
Capital Expenditures -91 -307 -240 -168 -106
Other Investing Cash Flow Items, Total -6 23 21 23 -4
Cash From Financing Activities -73 -685 -495 -320 -189
Financing Cash Flow Items -18 -8 -5 -5 -4
Total Cash Dividends Paid -37 -154 -117 -78 -40
Issuance (Retirement) of Stock, Net -12 -444 -300 -224 -138
Issuance (Retirement) of Debt, Net -6 -79 -73 -13 -7
Foreign Exchange Effects 6 -32 -63 -31 -9
Net Change in Cash -283 -247 -183 -203 -306
Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
The Vanguard Group, Inc. Investment Advisor/Hedge Fund 10.9994 16327351 -1269212 2023-06-30 LOW
Fidelity Management & Research Company LLC Investment Advisor 10.899 16178244 3050965 2023-06-30 LOW
BlackRock Institutional Trust Company, N.A. Investment Advisor 10.4485 15509530 -559319 2023-06-30 LOW
State Street Global Advisors (US) Investment Advisor/Hedge Fund 2.9477 4375521 -63310 2023-06-30 LOW
JP Morgan Asset Management Investment Advisor 2.0826 3091411 364338 2023-06-30 LOW
MFS Investment Management Investment Advisor/Hedge Fund 1.9274 2861054 945287 2023-06-30 LOW
LSV Asset Management Investment Advisor 1.89 2805413 -70900 2023-06-30 LOW
Fidelity Institutional Asset Management Investment Advisor 1.8474 2742250 612649 2023-06-30 LOW
Columbia Threadneedle Investments (US) Investment Advisor/Hedge Fund 1.7524 2601197 698906 2023-06-30 LOW
Dimensional Fund Advisors, L.P. Investment Advisor/Hedge Fund 1.7075 2534526 57481 2023-06-30 LOW
Mellon Investments Corporation Investment Advisor/Hedge Fund 1.64 2434404 256085 2023-09-30 LOW
Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 1.4812 2198740 103239 2023-06-30 LOW
Newton Investment Management Ltd. Investment Advisor 1.2712 1886938 -25115 2023-09-30 LOW
Citadel Advisors LLC Hedge Fund 1.227 1821403 1655823 2023-06-30 LOW
Norges Bank Investment Management (NBIM) Sovereign Wealth Fund 1.0344 1535378 70665 2022-12-31 LOW
American Century Investment Management, Inc. Investment Advisor/Hedge Fund 0.9764 1449388 155848 2023-06-30 LOW
Vaughan Nelson Investment Management, L.P. Investment Advisor 0.8857 1314736 58324 2023-06-30 LOW
Northern Trust Investments, Inc. Investment Advisor/Hedge Fund 0.8062 1196682 85287 2023-06-30 LOW
Legal & General Investment Management Ltd. Investment Advisor/Hedge Fund 0.7315 1085781 854889 2023-06-30 LOW
Charles Schwab Investment Management, Inc. Investment Advisor 0.6973 1035108 31916 2023-06-30 LOW

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Chemours Company profile

About Chemours Co

The Chemours Company is a provider of performance chemicals. The Company’s principal products include titanium dioxide (TiO2) pigments, refrigerants, industrial fluoropolymer resins, sodium cyanide, and performance chemicals and intermediates. The Company operates through four segments: Titanium Technologies, Thermal & Specialized Solutions, Advanced Performance Materials, and Chemical Solutions. The Titanium Technologies segment is a provider of TiO2 pigment, a premium white pigment used to deliver whiteness, brightness, opacity, and protections in a variety of applications. The Thermal & Specialized Solutions segment is a provider of refrigerants, propellants, blowing agents, and specialty solvents. The Advanced Performance Materials segment is a provider of high-end polymers and advanced materials. The Chemical Solutions segment is a North American provider of industrial chemicals used in gold production, industrial, and consumer applications.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, Chemours Co revenues increased 28% to $6.35B. Net income increased from $219M to $608M. Revenues reflect Titanium Technologies segment increase of 40% to $3.36B, Asia Pacific segment increase of 32% to $1.83B, North America segment increase of 21% to $2.32B. Net income benefited from Gain on sales of assets and businesses increase from $8M to $115M (income), Restructuring and asset related charges.

Industry: Diversified Chemicals

1007 Market St
WILMINGTON
DELAWARE 19801
US

Income Statement

  • Annual
  • Quarterly

News

Facade on the Federal Reserve Building in Washington DC

Central Banks: which one will cut first?

Central banks dominate the calendar in March and markets try to anticipate which one will be the first one to cut

18:44, 1 March 2024

Nvidia (NVDA) confronts high expectations for Q4 results

Nvidia is arguably the hottest company on the planet. The company reports its Q4 results after the closing bell on Wednesday, the 21st of February. We preview what to expect from Nvidia’s earnings and analyse the technicals of its stock price.

12:13, 20 February 2024

UK Bank Earnings: What to expect from Lloyds, Barclays and HSBC?

UK banks will be in the spotlight in the week ahead as the European earnings season continues

16:38, 16 February 2024

Is Big Tech behind the apparent bull market rally?

While the Magnificent Seven have dominated market momentum in recent months, it’s not true that they are the sole drivers of the recent rally in equity markets.

16:05, 8 February 2024

US Earnings Week Ahead: Walt Disney, Uber, and Pepsi Co.

The last of the Magnificent Seven have reported, delivering mixed results. Meanwhile, according to FactSet, the S&P 500 is set for negative earnings growth for Q4, with estimates for the next quarter also downgraded.

16:24, 2 February 2024

Bank of England preview: will updated projections show more cuts are expected in 2024?

Markets have no doubt that the BoE will keep its rate unchanged

15:43, 31 January 2024

Meta Platforms Q4 earnings forecast to surge on solid ad revenues

Meta Platforms (META) reports its Q4 results after Wall Street’s closing bell on February 1, 2024. We preview what to expect from the results and analyse the stock’s technicals.

15:33, 31 January 2024

People also watch

BTC/USD

67,145.60 Price
-0.620% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 106.00

US100

18,129.90 Price
-0.400% 1D Chg, %
Long position overnight fee -0.0262%
Short position overnight fee 0.0040%
Overnight fee time 22:00 (UTC)
Spread 1.8

Gold

2,115.48 Price
+0.050% 1D Chg, %
Long position overnight fee -0.0189%
Short position overnight fee 0.0107%
Overnight fee time 22:00 (UTC)
Spread 0.30

Oil - Crude

77.98 Price
-0.500% 1D Chg, %
Long position overnight fee 0.0260%
Short position overnight fee -0.0479%
Overnight fee time 22:00 (UTC)
Spread 0.040

Still looking for a broker you can trust?

Join the 580.000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading